Cargando…
COVID-19 alters thinking and management in metabolic diseases
Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687210/ https://www.ncbi.nlm.nih.gov/pubmed/33239662 http://dx.doi.org/10.1038/s41574-020-00449-y |
| _version_ | 1783613481660973056 |
|---|---|
| author | le Roux, Carel W. |
| author_facet | le Roux, Carel W. |
| author_sort | le Roux, Carel W. |
| collection | PubMed |
| description | Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients with metabolic disease, but without COVID-19, to prioritize for treatment during and immediately after the pandemic. |
| format | Online Article Text |
| id | pubmed-7687210 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76872102020-11-25 COVID-19 alters thinking and management in metabolic diseases le Roux, Carel W. Nat Rev Endocrinol Year in Review Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients with metabolic disease, but without COVID-19, to prioritize for treatment during and immediately after the pandemic. Nature Publishing Group UK 2020-11-25 2021 /pmc/articles/PMC7687210/ /pubmed/33239662 http://dx.doi.org/10.1038/s41574-020-00449-y Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Year in Review le Roux, Carel W. COVID-19 alters thinking and management in metabolic diseases |
| title | COVID-19 alters thinking and management in metabolic diseases |
| title_full | COVID-19 alters thinking and management in metabolic diseases |
| title_fullStr | COVID-19 alters thinking and management in metabolic diseases |
| title_full_unstemmed | COVID-19 alters thinking and management in metabolic diseases |
| title_short | COVID-19 alters thinking and management in metabolic diseases |
| title_sort | covid-19 alters thinking and management in metabolic diseases |
| topic | Year in Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687210/ https://www.ncbi.nlm.nih.gov/pubmed/33239662 http://dx.doi.org/10.1038/s41574-020-00449-y |
| work_keys_str_mv | AT lerouxcarelw covid19altersthinkingandmanagementinmetabolicdiseases |